CDK12 is a context-specific tumorigenesis regulator and novel therapeutic target in castration-resistant prostate cancer

Ended Project Grant Awarded Last action

Award ID
W81XWH2110458
Recipient
Awarding agency
Obligated
$925,834

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Ann Arbor, MI 48109, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The University of Michigan received a $925,834 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The grant will fund research into CDK12 as a context-specific tumorigenesis regulator and novel therapeutic target in castration-resistant prostate cancer. The research will be performed in Ann Arbor, Michigan over a three-year period from September 2021 through August 2024. Through the support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform health care for service members and the public by investigating medical solutions for the battlefield and beyond. This award supports those goals by furthering understanding of cancer biology that could lead to new treatment approaches for prostate cancer.

Quick answers

Who received award W81XWH2110458?

W81XWH2110458 was awarded to Regents Of The University Of Michigan by Medical Command (Department of the Army) on September 1, 2021.

How much is award W81XWH2110458 worth?

$925,834 has been obligated on W81XWH2110458.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login